U.S., March 12 -- ClinicalTrials.gov registry received information related to the study (NCT07465198) titled 'Autologous Stem Cell Therapy in Patients With Multiple System Atrophy' on Sept. 03, 2025.
Brief Summary: This study investigates the safety and efficacy of autologous stem cell therapy in patients with Multiple System Atrophy (MSA), a rare and progressive neurodegenerative disorder characterized by autonomic failure, parkinsonism, and cerebellar ataxia. The trial will evaluate functional outcomes, motor performance, and quality of life compared to placebo/controlled group.
Study Start Date: Sept. 01, 2026
Study Type: INTERVENTIONAL
Condition:
MSA - Multiple System Atrophy
MSA
Intervention:
DRUG: MSCs
IV infusion of 200,000,0...